Today afternoon, May 5th, doctors will release the Prague patient who was the first in the Czech Republic to be treated with the experimental drug Remdesivir.
The man, a Prague taxi driver, was admitted to the General University Hospital on March 10 in critical condition and has been on ventilation for many days.
Remdesivir is an antiviral, intravenous medicine made by Gilead Sciences that’s been around for years as an experimental compound, but was never approved by the Food and Drug Administration — or any other country’s drug approval agency.
Remdesivir was one of the drugs being studied in 2014 as a potential Ebola treatment but was sidelined in favor of other treatments and vaccines.
The Czech Republic had 7,819 confirmed cases of coronavirus infection by Tuesday morning, with 38 new infections on Monday. So far 3,807 people have recovered and 252 people have died.